Objectives:

1. Describe the various clinical presentations of joint pain in the IBD population.

2. Understand the overlapping immunopathology between inflammatory bowel disease (IBD) and other forms of spondyloarthritis (SpA).

3. Discuss current treatment strategies aimed at controlling the extra-gastrointestinal disease.

4. Evaluate potential of newer drugs to address these symptoms.